About EFA
EFA - a brief history...
The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is a European network of allergy, asthma and COPD patient organizations that was founded in 1991 in Stockholm, Sweden.
EFA was created to combine the forces of national patient associations on asthma and allergy for results at European level and to improve the health and quality of life of people in Europe with those diseases. Serving the interests of allergy and airways patients at the national level is the primary responsibility of individual members and EFA represents member organisations at European level by facilitating collaboration, sharing of knowledge and experiences.
EFA's founding countries were: Finland, Germany, Iceland, the Netherlands, Norway, Poland, Sweden and the United Kingdom.
Chronic Obstructive Pulmonary Disease (COPD) was added to EFA's mandate in 2002.
EFA membership now covers most of the European Union countries:Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Lithuania, Luxembourg, Netherlands, Norway, Portugal, Slovenia, Sweden, Switzerland and the UK. There are over 400.000 patient and carer members in EFA member organisations.
EFA is an independent non-profit organization and its office is located in Brussels, Belgium.
SUSTAINABLE PARTNERSHIPS
2011 funding
EFA sustainable corporate partnership framework
Code of Ethics and Conduct
Membership fees
30.000
European Commission DG Research
67.200
European Commission DG Health
5.000
Sustainable industry partnerships
5 Star*****
- GlaxoSmithKline - 55.000
- Novartis - 55.000
3 Star***
- ALK Abelló - 30.000
- Air Liquide Healthcare - 30.000 - EFA welcomes as our new partner!
- AstraZeneca - EFA welcomes as our new partner!
- BoehringerIngelheim - 30.000
- Chiesi - 30.000
- Nycomed - 30.000
- Pfizer - 30.000
- Stallergenes - 30.000 - EFA welcomes as our new partner!
COPD Project
140.000 Air Liquide Healthcare, Astra Zeneca, Boehringer Ingelheim, GSK, Novartis, Nycomed, Pfizer. 20.000 each
Allergy project
50.000 ALK Abelló, Stallergenes. 25.000 each
EFA thanks our sponsors who are making our work on behalf of people with allergy, asthma and COPD possible!
Last update 12/04/2011
Additional information
More Information
EFA's Vision
What is EFA’s guiding vision of success?
EFA's external vision is directly
related to the mission of EFA and focuses on the question of how successful we will be in:
• Influencing policymaking
• Supporting the creation of a European network of strong and professional national organisations
• Empowering member organisations to ensure patients' interests are served in a comparable way across Europe.